Acessibilidade / Reportar erro

Comparison of the quantitative competitive and semiquantitative RT-PCR methods for the determination of interferon-gamma mRNA levels in AIDS-free HIV-infected individuals

Abstract

IFN-gamma mRNA expression was evaluated in nonstimulated peripheral blood mononuclear cells (PBMC) of HIV-infected and seronegative individuals using quantitative competitive and semiquantitative RT-PCR and the sensitivity of these methods was compared. A significant correlation was found between quantitative competitive and semiquantitative RT-PCR in samples of both HIV-seronegative (P = 0.004) and HIV-infected individuals (P = 0.0004). PBMC from HIV-infected individuals presented a remarkable increase of IFN-gamma mRNA expression, as determined by both types of RT-PCR methods. Semiquantitative RT-PCR even without an internal standard is also acceptable for measuring cytokine mRNA expression, but less reliable if small amounts are quantified. Moreover, we found that increased IFN-gammamRNA expression is independent of CD4+ cell count in AIDS-free HIV-infected patients.

quantitative competitive RT-PCR; semiquantitative RT-PCR; IFN-gamma mRNA; HIV


Braz J Med Biol Res, October 2001, Volume 34(10) 1271-1275 (Short Communication)

Comparison of the quantitative competitive and semiquantitative RT-PCR methods for the determination of interferon-gamma mRNA levels in AIDS-free HIV-infected individuals

É. Barabás, K. Nagy, V. Várkonyi and A. Horváth

National Institute of Dermato-Venereology, Budapest, Hungary

Text

References

Correspondence and Footnotes Correspondence and Footnotes Correspondence and Footnotes

Abstract

IFN-g mRNA expression was evaluated in nonstimulated peripheral blood mononuclear cells (PBMC) of HIV-infected and seronegative individuals using quantitative competitive and semiquantitative RT-PCR and the sensitivity of these methods was compared. A significant correlation was found between quantitative competitive and semiquantitative RT-PCR in samples of both HIV-seronegative (P = 0.004) and HIV-infected individuals (P = 0.0004). PBMC from HIV-infected individuals presented a remarkable increase of IFN-g mRNA expression, as determined by both types of RT-PCR methods. Semiquantitative RT-PCR even without an internal standard is also acceptable for measuring cytokine mRNA expression, but less reliable if small amounts are quantified. Moreover, we found that increased IFN-g mRNA expression is independent of CD4+ cell count in AIDS-free HIV-infected patients.

Key words: quantitative competitive RT-PCR, semiquantitative RT-PCR, IFN-g mRNA, HIV

Cytokines are important regulators of immune responses. It has been suggested that a change in cytokine production occurs in HIV infection (1,2). Most of these studies measured cytokine levels after stimulation of peripheral blood mononuclear cells (PBMC) in vitro due to the low concentration of cytokines under nonstimulated conditions (3). In contrast, determination of cytokine mRNA expression in nonstimulated PBMC would provide information about alterations in the cytokine network as a direct consequence of HIV (2-9).

IFN-g has an important role in the course of HIV infection (1-9), although its significance is not well understood. Both deficiency (1,2) and overproduction (4-9) of IFN-g have been reported in different studies.

Exact amounts of expressed cytokines can be quantified by means of highly sensitive methods. In the present study we determined IFN-g:ß-actin mRNA ratios by quantitative competitive reverse transcriptase polymerase chain reaction (QC RT-PCR) in nonstimulated PBMC from HIV-infected patients and healthy controls. The results were compared to those obtained by semiquantitative RT-PCR (SQ RT-PCR).

Twenty-five HIV-seropositive patients were selected at the HIV outpatient clinic of the National Institute of Dermato-Venereology, Budapest, Hungary. Six subjects with a CD4+ cell count <200/µl (HIV <200), 12 patients with a CD4+ cell count 300-400/µl (HIV = 300), and 7 subjects with a CD4+ cell count >500/µl (HIV >500) were included. Clinical examination showed no evidence of malignancies or rapid progression of the disease. None of them received antiretroviral therapy. Eleven HIV-seronegative healthy volunteers served as controls.

PBMC were separated from blood by Ficoll (Amersham Pharmacia Biotech, Uppsala, Sweden) density gradient centrifugation. Cells were suspended in cell membrane lysing solution (guanidine isothiocyanate-ß-mercaptoethanol, Sigma, St. Louis, MO, USA). Total cellular RNA was purified (10). RT of RNA was performed according to the Perkin-Elmer protocol (Perkin-Elmer, Branchburg, NJ, USA). A thermocycler (PDR-91, BLS) was used for RT reaction (20 min at 42ºC, then 10 min at 99ºC). Two RT samples from each PBMC extract were used for RT-PCR methods.

Semiquantitative reverse RT-PCR. cDNA equivalent to 500 ng total RNA was amplified. PCR was performed in a final volume of 50 µl containing 10 µl RT transcript, 2 µl MgCl2 (25 mM), 4 µl 10-fold buffer II (500 mM KCl, 100 mM Tris-HCl, pH 8.3), 15 pM of each primer, and 0.25 µl Taq polymerase (5 U/µl, Perkin-Elmer). The following primers were used: ß-actin sense, 5' GTGGGGCGCCCCAGGCACCA 3'; antisense, 5' CTCCTTAATGTCACGCACGATTTC 3'; IFN-g sense, 5' AGTTATATCTTGGCTTTTCA 3'; antisense, 5' ACCGAATAATTAGTCAGCTT 3' (Promega, Madison, WI, USA). Samples were amplified using different cycle numbers: ß-actin, 25 cycles (annealing at 65ºC) and IFN-g, 30 cycles (annealing at 52ºC) each. PCR products (18 µl) were electrophoresed on 2.5% agarose gel and visualized under ultraviolet light after ethidium bromide staining. Fragment sizes were 540 bp for ß-actin and 356 bp for IFN-g. mRNA expression of ß-actin and IFN-g was determined with a video-densitometry system (Eagleeye II, Amersham). Subsequently the IFN-g:ß-actin ratio (mRNAs were detected in the same RT sample) in densitometric units was calculated in the analytical process (2-4,6,8).

Quantitative competitive RT-PCR. cDNA equivalent to 400 ng total RNA was quantified by coamplification with nonhomologous internal standard fragments. Internal standard fragments for ß-actin and IFN-g were prepared as previously described (11). A composite primer was used for the first reamplification step. 5' CTCCTTAATGTCACGCACGATTTCCGTAGATGGGCACAGTGTGG 3' (annealing 60ºC) was used for ß-actin and 5' ACCGAATAATTAGTCAGCTTGAGAACAATTTGGCTCTGC 3' (annealing 48ºC) (Promega) was used for IFN-g. Fragment size of the internal standards was 397 bp for ß-actin and 227 bp for IFN-g. Concentrations of internal standard stock solutions were determined by absorbance measurement at 260 nm. Molar concentrations (mol/l = M) of stock solutions were 10-7 M for ß-actin and 10-8 M for IFN-g. Competitor stocks were diluted on a 0.5-log scale. PCR was performed in a final volume of 50 µl containing 8 µl RT transcript and 1 µl diluted internal standard. Thirty cycles were used for ß-actin and 35 for IFN-g. PCR products were amplified and detected as described in the previous section. The IFN-g:ß-actin ratio (M/M) was used for the subsequent analysis.

Data were analyzed using the Statistica for Windows 5.1 software (12). Comparisons between groups were made by the Mann-Whitney U-test. Comparisons between QC RT-PCR and SQ RT-PCR results were performed by Pearson product-moment correlation and by Spearman rank correlation. Significance was defined as P<0.05.

IFN-g mRNA expression determined by the IFN-g:ß-actin ratio showed a definite increase in both QC RT-PCR and SQ RT-PCR reactions. Quantitative competitive IFN-g:ß-actin mRNA ratios (M/M) were significantly higher in all HIV-infected groups than in the HIV-seronegative group. There was no difference among HIV-positive groups with different CD4+ cell counts. Most IFN-g:ß-actin mRNA ratios were below 10-4 (M/M)among seronegative individuals, while they were above 10-4 (M/M) among HIV-infected patients (Figure 1A).

Semiquantitative analysis showed significantly increased IFN-g:ß-actin values in HIV <200 and HIV >500 patients compared to the seronegative group. The IFN-g:ß-actin ratio was higher in the HIV = 300 group than in the control group, but this difference was not statistically significant. There was no difference in IFN-g:ß-actin values among the HIV-positive groups (Figure 1B).

A correlation between QC RT-PCR and SQ RT-PCR ratios could be found in both the HIV-negative (Figure 1C) and HIV-positive groups (Figure 1D).

Longitudinal study of six representative individuals showed that the QC RT-PCR IFN-g:ß-actin ratio was below 10-4 (M/M) regarding HIV-negative individuals (Figure 2A-C) and above 10-4 (M/M) regarding HIV-positive patients (Figure 2D-F) at most time points. Variation of IFN-g levels was rather high in HIV-positive patients. QC RT-PCR and SQ RT-PCR showed a similar tendency in all longitudinal studies.

QC RT-PCR was shown to be more sensitive than SQ RT-PCR. Based on our findings, the QC RT-PCR system identified smaller differences between samples than the SQ RT-PCR method. Correlation analysis revealed weaker significance between QC RT-PCR and SQ RT-PCR results in healthy control than in HIV-positive samples, indicating that SQ RT-PCR was less reliable for smaller amounts of IFN-g.

Correlation between results obtained by RT-PCR methods with different sensitivity showed that SQ RT-PCR, even without an internal standard, is also a reliable method for quantifying cytokine mRNA activity. Measuring a sample of large size is simple and fast. Using only SQ RT-PCR to measure cytokines, which are expressed at low levels, however, requires caution since the reliability of this method is lower when small amounts of mRNA are quantified.

Results of earlier studies on IFN-g expression measured by RT-PCR were controversial. Some studies reported a stronger IFN-g expression in HIV-infected samples (4-9), others in HIV-negative samples (1,2), and still others could not find any differences (3). We found significantly elevated IFN-g expression in AIDS-free HIV-positive patients by a less sensitive as well as a highly sensitive RT-PCR method. Independently of the duration of HIV infection and total CD4+ cell count, a marked increase of IFN-g mRNA expression could be observed by both methods.

Recently, it was reported that the major source of IFN-g in both HIV-seronegative and HIV-infected individuals is represented by CD8+ T cells (7,9). Our results support the idea that permanent presentation of HIV-1 antigens causes a strong CD8+ response in the asymptomatic phase, which also manifests as a permanent IFN-g activity. IFN-g has a role in the activation of some antiviral killing mechanisms. However, there are other deficiencies in the immune system which can counteract the effective antiviral activity. It may be suggested that IFN-g mRNA activity in the AIDS-free phase may be correlated with the activation of the immune system, which contributes to virus replication and spread in the human body (7).

Figure 1.
Elevated interferon-g mRNA levels in AIDS-free HIV-infected individuals.
A, IFN-g:ß-actin mRNA ratios (ratio of molar concentrations = M/M) in HIV-seronegative (healthy controls, HC) and HIV-infected patients by quantitative competitive RT-PCR. B, IFN-g:ß-actin mRNA ratios (ratio in densitometric units = RDU) for HC and HIV-infected patients evaluated by semiquantitative RT-PCR. HIV-seropositive patients are divided into three groups based on CD4+ cell counts. The Mann-Whitney U-test was used for group comparisons. Significant differences between HIV-infected and HC groups are indicated. Correlation between quantitative competitive RT-PCR and semiquantitative RT-PCR IFN-g:ß-actin mRNA ratios for HC samples (C) and HIV-infected samples (D). Pearson product-moment (*) and Spearman rank (**) correlations were used for the calculations (C,D). Each individual is indicated as a single point (A-D).

[View larger version of this image (30 K GIF file)]

Figure 2.
Longitudinal study of the IFN-g:ß-actin mRNA ratio evaluated by quantitative competitive RT-PCR (ratio of molar concentrations = M/M) (lozenges) and semiquantitative RT-PCR (ratio of densitometric units = RDU) (squares):
A-C, three HIV-seronegative individuals; D-F, three HIV-infected patients.

[View larger version of this image (34 K GIF file)]

Acknowledgments

We gratefully acknowledge the technical assistance of Gyöngyi Daróczi. We also thank Zsuzsa Faragó and Ágnes Végh for collection of blood samples, and Béla Kemény and József Bocsi for the flow cytometry analysis.

Address for correspondence: É. Barabás, National Institute of Dermato-Venereology, Mária utca. 41, H-1085 Budapest, Hungary. Fax: +36-1-267-6974. E-mail: Bareva@bor.sote.hu

Received November 27, 2000. Accepted July 25, 2001.

  • 1. Clerici M & Shearer M (1993). A Th1-Th2 switch is a critical step in the etiology of HIV infection. Immunology Today, 14: 107-111.
  • 2. Diaz-Mitoma F, Kumar A & Karimi S (1995). Expression of IL-10 and IL-4 and interferon-gamma in unstimulated and mitogen stimulated peripheral blood lymphocytes from HIV-seropositive patients. Clinical and Experimental Immunology, 102: 31-39.
  • 3. Altfeld M, Addo MM, Kreutzer KA, Rockstroh JK, Dumoulin FL, Schliefer K, Leifeld L, Sauerbruch T & Spengler U (2000). TH1 to TH2 shift of cytokines in peripheral blood of HIV-infected patients is detectable by reverse transcriptase polymerase chain reaction but not by enzyme-linked immunosorbent assay under nonstimulated conditions. Journal of Acquired Immune Deficiency Syndromes, 23: 287-294.
  • 4. Fan J, Bass HZ & Fahey JL (1993). Elevated IFN-g and decreased IL-2 gene expression are associated with HIV infection. Journal of Immunology, 151: 5031-5040.
  • 5. Graziosi C, Pantaleo P, Gantt KR, Fortin JP, Demarest JF, Cohen OJ, Sékaly RP & Fauci AS (1994). Lack of evidence for the dichotomy of Th1 and Th2 predominance in HIV-infected individuals. Science, 265: 248-252.
  • 6. McGown I, Radford-Smith G & Jewell DP (1994). Cytokine gene expression in HIV-infected intestinal mucosa. AIDS, 8: 1569-1575.
  • 7. Crabb-Breen E, Salazar-Gonzalez JF, Shen PL, Kolberg JA, Urdea MS, Martinez-Maza O & Fahey JL (1997). Circulating CD8 T cells show increased interferon-g mRNA expression in HIV infection. Cellular Immunology, 178: 91-98.
  • 8. Barabás É, Falus A, Nagy K, Várkonyi V, Temesvári E & Horváth A (1997). The dominant T-helper lymphocyte function of HIV infected patients. Pathology Oncology Research, 3: 67-73.
  • 9. Empson M, Bishop GA, Nightingale B & Garcia R (1999). Atopy, anergic status, and cytokine expression in HIV-infected subjects. Journal of Allergy and Clinical Immunology, 103: 833-842.
  • 10. Chomczynski P & Sacchi N (1987). Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Analytical Biochemistry, 162: 156-159.
  • 11. Förster E (1994). An improved general method to generate internal standards for competitive PCR. BioTechniques, 16: 18-20.
  • 12. StatSoft, Inc. (1997). Statistica for Windows. Tulsa, OK, USA.
  • Figure 1. Elevated interferon-g mRNA levels in AIDS-free HIV-infected individuals. A, IFN-g:ß-actin mRNA ratios (ratio of molar concentrations = M/M) in HIV-seronegative (healthy controls, HC) and HIV-infected patients by quantitative competitive RT-PCR. B, IFN-g:ß-actin mRNA ratios (ratio in densitometric units = RDU) for HC and HIV-infected patients evaluated by semiquantitative RT-PCR. HIV-seropositive patients are divided into three groups based on CD4+ cell counts. The Mann-Whitney U-test was used for group comparisons. Significant differences between HIV-infected and HC groups are indicated. Correlation between quantitative competitive RT-PCR and semiquantitative RT-PCR IFN-g:ß-actin mRNA ratios for HC samples (C) and HIV-infected samples (D). Pearson product-moment (*) and Spearman rank (**) correlations were used for the calculations (C,D). Each individual is indicated as a single point (A-D).
  • Figure 2. Longitudinal study of the IFN-g:ß-actin mRNA ratio evaluated by quantitative competitive RT-PCR (ratio of molar concentrations = M/M) (lozenges) and semiquantitative RT-PCR (ratio of densitometric units = RDU) (squares): A-C, three HIV-seronegative individuals; D-F, three HIV-infected patients.
  • Correspondence and Footnotes

  • Publication Dates

    • Publication in this collection
      02 Oct 2001
    • Date of issue
      Oct 2001

    History

    • Accepted
      25 July 2001
    • Received
      27 Nov 2000
    Associação Brasileira de Divulgação Científica Av. Bandeirantes, 3900, 14049-900 Ribeirão Preto SP Brazil, Tel. / Fax: +55 16 3315-9120 - Ribeirão Preto - SP - Brazil
    E-mail: bjournal@terra.com.br